PFK-015
CAS No. 4382-63-2
PFK-015( PFK015 | PFK 015 | PFK015. )
Catalog No. M18553 CAS No. 4382-63-2
PFK-015 is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 47 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 146 | In Stock |
|
| 50MG | 267 | In Stock |
|
| 100MG | 397 | In Stock |
|
| 200MG | 551 | In Stock |
|
| 500MG | 878 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePFK-015
-
NoteResearch use only, not for human use.
-
Brief DescriptionPFK-015 is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).
-
DescriptionPFK-015 is a potent inhibitor of PFKFB3. The preliminary results in a U87GM xenograft model have shown that PFK-015 has comparable activity to Temozolomide. PFK-015 inhibits glucoseuptake by tumors.
-
In VitroPFK-015 inhibits tumor growth in a dose-dependent manner in esophageal cancer cell line in vitro. PFK-015 (0-5 μM) increases HIF-1α mediated PD-L1 transcriptional activity.PFK-015 induces the expression of tumor PD-L1 via the phos-PFKFB3/HIF-1a axis.PFK-015 potently inhibits recombinant PFKFB3 with an IC50 value of 110 nM and inhibits PFKFB3 activity in cancer cells with an IC50 value of 20 nM.PFK-015 inhibits cancer cell proliferation in a panel of 17 cancer cell lines and suppresses glucose uptake in cancer cells.
-
In VivoPFK-015 impeds ESCC tumor growth in immunodeficient in vivo models.PFK-015 (0-12.5 μM, 48 h) induces tumor PD-L1 expression.PFK-015 (0-12.5 μM, 48 h) can cause a downregulation of immune activity against tumor cells mediated by CD8 + T cells.PFK-015 enhances the efficacy of ESCC by enhancing CD8 + T-cell activity combining PD-1 mAb in immunocompetent mouse models such as C57BL/6 and hu-PBMC-NOG.PFK-015 (iv, 5 mg/kg) has a satisfactory half-life, exposure, tissue distribution and reasonable clearance.
-
SynonymsPFK015 | PFK 015 | PFK015.
-
PathwayOthers
-
TargetOther Targets
-
RecptorPFKFB3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number4382-63-2
-
Formula Weight260.29
-
Molecular FormulaC17H12N2O
-
Purity>98% (HPLC)
-
SolubilityDMSO : 25.2 mg/mL 96.82 mM; H2O : < 0.1 mg/mL
-
SMILESC(=O)(/C=C/c1nc2c(cc1)cccc2)c1ccncc1
-
Chemical Name(E)-3-(pyridin-3-yl)-1-(quinolin-3-yl)prop-2-en-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
[Lys1015,1024]-Throm...
4N1K peptide is a biological active peptide. (4N1K-peptide (KRFYVVMWKK), which is derived from thrombospondins has anti-cancer activities in several cancers)
-
N-Isovalerylglycine
Isovalerylglycine (IVG) is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation.
-
D-(-)-Pantolactone
Pantolactone belongs to the class of organic compounds known as gamma-butyrolactones. gamma-Butyrolactones are compounds containing a gamma-butyrolactone moiety which consists of an aliphatic five-member ring with four carbon atoms one oxygen atom and bears a ketone group on the carbon adjacent to the oxygen atom.
Cart
sales@molnova.com